PHARMACY

Dr. Reddy’s launches generic version of Zyprexa

BY Alaric DeArment

HYDERABAD, India — Dr. Reddy’s Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

Dr. Reddy’s announced the launch of olanzapine tablets in the 2.5-mg, 5-mg, 7.5-mg, 10-mg and 15-mg strengths.

The drug is a generic version of Zyprexa, used to treat schizophrenia and bipolar disorder. Generic and branded versions of the drug had sales of about $3.28 billion during the 12-month period ended in January, according to IMS Health.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Reports: Watson to buy Actavis

BY Alaric DeArment

NEW YORK — Watson Pharmaceuticals is buying Actavis Group for $5.9 billion, according to published reports.

News media reported Tuesday that U.S.-based Watson would buy Switzerland-based Actavis for 4.5 billion euros and that it would make the official announcement Wednesday.

In March, various media reported that Watson was looking to buy Actavis, originally based in Iceland, for up to $7.3 billion in a deal that was seen as likely to go through by the end of this month.

According to reports, people familiar with the matter suggested that part of the reason for the merger was to give Watson a larger presence in Europe.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

NACDS Foundation awards $350K in pharmacy school scholarships

BY Allison Cerra

PALM BEACH, Fla. — The National Association of Chain Drug Stores Foundation announced that $350,000 in scholarships were awarded through its 2012 pharmacy partners scholarship program.

The announcement was made at the NACDS Annual meeting in Palm, Beach, Fla.

The scholarship program this year provided awards ranging from $1,000 to $20,000 to each pharmacy school’s scholarship fund to assist pharmacy students working to achieve their professional Doctor of Pharmacy degree. This year, the NACDS Foundation provided scholarship assistance to each of the 126 accredited pharmacy schools and colleges in the nation.

The 2012 NACDS Foundation pharmacy partners scholarship program was supported by a group of 29 benefactors, comprised of NACDS chain members and associate members. The largest contributions were as follows:

  • $20,000 Apotex Wayne Roberts Memorial Scholarship awarded to University of Rhode Island College of Pharmacy;

  • $12,500 Boehringer Ingelheim Pharmaceuticals Scholarship awarded to Pacific University School of Pharmacy;

  • $10,000 Abbott — Pharmaceutical Products Division Scholarship awarded to University of Colorado School of Pharmacy;

  • $10,000 NACDS Foundation Scholarship awarded to University of Georgia College of Pharmacy;

  • $10,000 NACDS Foundation Scholarship awarded to Rosalind Franklin University College of Pharmacy; and

  • $10,000 NACDS Foundation Scholarship awarded to St. John Fisher College Wegmans School of Pharmacy.

"We cannot thank the benefactors enough for their support of the NACDS Foundation pharmacy partners scholarship program," NACDS Foundation president Kathleen Jaeger said. "Their generous contributions for this year’s scholarships further illustrate the unwavering commitment by retail pharmacy and the pharmaceutical industries to advancing patient care and pharmacy education by supporting the next generation of leaders in community pharmacy."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?